296 related articles for article (PubMed ID: 2068317)
1. MR evaluation of CNS tumors: dose comparison study with gadopentetate dimeglumine and gadoteridol.
Yuh WT; Fisher DJ; Engelken JD; Greene GM; Sato Y; Ryals TJ; Crain MR; Ehrhardt JC
Radiology; 1991 Aug; 180(2):485-91. PubMed ID: 2068317
[TBL] [Abstract][Full Text] [Related]
2. MR diagnosis of head and neck tumors: comparison of contrast enhancement with triple-dose gadodiamide and standard-dose gadopentetate dimeglumine in the same patients.
Vogl TJ; Mack MG; Juergens M; Stark M; Pegios W; Bergman C; Grevers G; Western A
AJR Am J Roentgenol; 1994 Aug; 163(2):425-32. PubMed ID: 8037044
[TBL] [Abstract][Full Text] [Related]
3. Triple-dose versus standard-dose gadopentetate dimeglumine: a randomized study in 199 patients.
Haustein J; Laniado M; Niendorf HP; Louton T; Beck W; Planitzer J; Schöffel M; Reiser M; Kaiser W; Schörner W
Radiology; 1993 Mar; 186(3):855-60. PubMed ID: 8430199
[TBL] [Abstract][Full Text] [Related]
4. Gadodiamide injection and gadopentetate dimeglumine. A double-blind study in MR imaging of the CNS.
Myhr G; Rinck PA; Børseth A
Acta Radiol; 1992 Sep; 33(5):405-9. PubMed ID: 1389644
[TBL] [Abstract][Full Text] [Related]
5. MRI evaluation of "solitary" brain metastases with triple-dose gadoteridol: comparison with contrast-enhanced CT and conventional-dose gadopentetate dimeglumine MRI studies in the same patients.
Kuhn MJ; Hammer GM; Swenson LC; Youssef HT; Gleason TJ
Comput Med Imaging Graph; 1994; 18(5):391-9. PubMed ID: 7954317
[TBL] [Abstract][Full Text] [Related]
6. MR arthrography of the shoulder with gadopentetate dimeglumine: influence of concentration, iodinated contrast material, and time on signal intensity.
Kopka L; Funke M; Fischer U; Keating D; Oestmann J; Grabbe E
AJR Am J Roentgenol; 1994 Sep; 163(3):621-3. PubMed ID: 8079856
[TBL] [Abstract][Full Text] [Related]
7. Effect of the rate of gadopentetate dimeglumine administration on abdominal vascular and soft-tissue MR imaging enhancement patterns.
Strouse PJ; Prince MR; Chenevert TL
Radiology; 1996 Dec; 201(3):809-16. PubMed ID: 8939236
[TBL] [Abstract][Full Text] [Related]
8. Magnetic resonance evaluation of brain metastases from systemic malignances with two doses of gadobutrol 1.0 m compared with gadoteridol: a multicenter, phase ii/iii study in patients with known or suspected brain metastases.
Katakami N; Inaba Y; Sugata S; Tsurusaki M; Itoh T; Machida T; Tanaka H; Nakayama T; Morikawa T; Breuer J; Aitoku Y
Invest Radiol; 2011 Jul; 46(7):411-8. PubMed ID: 21467949
[TBL] [Abstract][Full Text] [Related]
9. Phase II clinical trial of gadoteridol injection, a low-osmolal magnetic resonance imaging contrast agent.
Carvlin MJ; De Simone DN; Meeks MJ
Invest Radiol; 1992 Aug; 27 Suppl 1():S16-21. PubMed ID: 1506148
[TBL] [Abstract][Full Text] [Related]
10. [Efficacy of gadobenate dimeglumine vs gadopentetate dimeglumine in contrast- enhanced magnetic resonance imaging for diagnosis of solitary brain metastases].
Wang QJ; Wang Y; Xu X; Xiao H; Ma L
Nan Fang Yi Ke Da Xue Xue Bao; 2011 Dec; 31(12):1968-73. PubMed ID: 22200693
[TBL] [Abstract][Full Text] [Related]
11. Gadobenate dimeglumine-enhanced MRI of the breast: analysis of dose response and comparison with gadopentetate dimeglumine.
Knopp MV; Bourne MW; Sardanelli F; Wasser MN; Bonomo L; Boetes C; Müller-Schimpfle M; Hall-Craggs MA; Hamm B; Orlacchio A; Bartolozzi C; Kessler M; Fischer U; Schneider G; Oudkerk M; Teh WL; Gehl HB; Salerio I; Pirovano G; La Noce A; Kirchin MA; Spinazzi A
AJR Am J Roentgenol; 2003 Sep; 181(3):663-76. PubMed ID: 12933457
[TBL] [Abstract][Full Text] [Related]
12. Primary and secondary brain tumors at MR imaging: bicentric intraindividual crossover comparison of gadobenate dimeglumine and gadopentetate dimeglumine.
Knopp MV; Runge VM; Essig M; Hartman M; Jansen O; Kirchin MA; Moeller A; Seeberg AH; Lodemann KP
Radiology; 2004 Jan; 230(1):55-64. PubMed ID: 14695387
[TBL] [Abstract][Full Text] [Related]
13. Contrast-enhanced MR imaging of the breast: comparison of two different doses of gadopentetate dimeglumine.
Heywang-Köbrunner SH; Haustein J; Pohl C; Beck R; Lommatzsch B; Untch M; Nathrath WB
Radiology; 1994 Jun; 191(3):639-46. PubMed ID: 8184040
[TBL] [Abstract][Full Text] [Related]
14. Contrast-enhanced MR angiography for the diagnosis of intracranial vascular disease: optimal dose of gadopentetate dimeglumine.
Jung HW; Chang KH; Choi DS; Han MH; Han MC
AJR Am J Roentgenol; 1995 Nov; 165(5):1251-5. PubMed ID: 7572513
[TBL] [Abstract][Full Text] [Related]
15. MR imaging of the brain in patients with AIDS: value of routine use of i.v. gadopentetate dimeglumine.
Jensen MC; Brant-Zawadzki M
AJR Am J Roentgenol; 1993 Jan; 160(1):153-7. PubMed ID: 8416615
[TBL] [Abstract][Full Text] [Related]
16. Low dose gadobenate dimeglumine for imaging of chronic myocardial infarction in comparison with standard dose gadopentetate dimeglumine.
Bauner KU; Reiser MF; Huber AM
Invest Radiol; 2009 Feb; 44(2):95-104. PubMed ID: 19077911
[TBL] [Abstract][Full Text] [Related]
17. MR imaging of pituitary region lesions with gadodiamide injection.
Hald JK; Skalpe IO; Bakke SJ; Nakstad PH
Acta Radiol; 1994 Jan; 35(1):65-9. PubMed ID: 8305277
[TBL] [Abstract][Full Text] [Related]
18. Magnetic resonance imaging contrast agents.
Runge VM
Curr Opin Radiol; 1992 Feb; 4(1):3-12. PubMed ID: 1739599
[TBL] [Abstract][Full Text] [Related]
19. Gd-HP-DO3A in clinical MR imaging of the brain.
Runge VM; Gelblum DY; Pacetti ML; Carolan F; Heard G
Radiology; 1990 Nov; 177(2):393-400. PubMed ID: 2217775
[TBL] [Abstract][Full Text] [Related]
20. Lumbosacral spine: early and delayed MR imaging after administration of an expanded dose of gadopentetate dimeglumine in healthy, asymptomatic subjects.
Jinkins JR; Rauch RA; Gee GT; Bazan C; Xiong L; Kashanian FK; Hanna EP
Radiology; 1995 Oct; 197(1):247-51. PubMed ID: 7568831
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
